Markets open

Becton, Dickinson and Company

BDX · NYSE

Analyst Consensus

Hold

16 analysts

$171

Current

—

Low

$175

Average

—

High

Average target implies +2.62% versus the current price.

The ratings synthesis for BDX has not been generated yet.

Rating Actions

No individual rating actions have been captured for BDXyet. Consensus figures above come from Nasdaq's aggregate feed.

Rating actions are extracted from published reporting. Each row links to its source.

Covering Firms

B OF A GLBL RES

BARCLAYS CAPITA

CITIGROUP

CO FORECST

EDWARD JONES

EVERCORE ISI

JEFFERIES & CO.

JP MORGAN SECUR

MORGAN STANLEY

PIPER SANDLER

RAYMOND JAMES

STIFEL NICOLAUS

TD COWEN

WELLS FARGO SEC

WILLIAM BLAIR

ZACKS RESEARCH

Symbol: BDX
Type: Stock
Sector: Health Care
Industry: Medical/Dental Instruments
Country: North America
Exchange: NYSE

BD is one of the world's largest pure-play medical technology companies with a Purpose of advancing the world of health by driving innovation across medical essentials, connected care, biopharma systems and interventional. The company supports those on the frontlines of healthcare by developing transformative technologies, services and solutions that optimize clinical operations and improve care for patients. Operating across the globe, with more than 60,000 employees, BD delivers billions of products annually that have a positive impact on global healthcare. By working in close collaboration with customers, BD can help enhance outcomes, lower costs, increase clinical efficiency, improve safety and expand access to healthcare.